CoChat

Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS‐R trials

Open access
Neal, Bruce, Perkovic, Vlado, Mahaffey, Kenneth W., Fulcher, Greg, Erondu, Ngozi, Desai, Mehul, Shaw, Wayne, Law, Gordon, Walton, Marc K., Rosenthal, Norm, de Zeeuw, Dick, Matthews, David R., on behalf of the CANVAS Program collaborative group · 2017 · Diabetes, Obesity and Metabolism
Cited by 104

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Two large cardiovascular outcome trials of canagliflozin, comprising the CANVAS Program, will complete in early 2017: the CANagliflozin cardioVascular A ssessment S tudy ( CANVAS ) and the CANagliflozin cardioVascular A ssessment S tudy– R enal ( CANVAS‐R ). Accruing data for the sodium glucose co‐transporter 2 ( SGLT2 ) inhibitor class has identified questions and opportunities that were not apparent when the trials were designed. Accordingly, a series of modifications have been made to the planned analyses. These updates will ensure that the data from the CANVAS Program will maximize advances in scientific knowledge and patient care. The specification of the analysis strategy prior to knowledge of the trial results, their design by the independent scientific trial S teering C ommittee, the detailed a priori definition of the analysis plans, and the external review provided by the US F ood and D rug A dministration all provide maximally efficient and robust utilization of the data. The CANVAS Program should significantly advance our understanding of the effects of canagliflozin, and the broader SGLT2 inhibitor class, on a range of important efficacy and safety outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.12924

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 7

  1. 10.1016/j.ahj.2013.05.007 · DOI · Paper page
  2. 10.1016/S2213-8587(16)00052-8 · DOI · Paper page
  3. 10.1136/bmj.c4848 · DOI · Paper page
  4. 10.1007/s13300-015-0117-z · DOI · Paper page
  5. 10.2337/dc14-1237 · DOI · Paper page
  6. 10.2337/dc15-1251 · DOI · Paper page
  7. Babre D, 2010, Medical coding in clinical trials, Persp Clin Res, 1, 29, 10.4103/2229-3485.71844 · doi:10.4103/2229-3485.71844

Cited by

Metadata

Authors
Neal, B., Perkovic, V., Mahaffey, K. W., Fulcher, G., Erondu, N., Desai, M., Shaw, W., Law, G., Walton, M. K., Rosenthal, N., de Zeeuw, D., Matthews, D. R., & on behalf of the CANVAS Program collaborative group
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2017-04-03
Volume
19
Issue
7
Pages
926-935
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2594590765
Cited by
104
References
3
FWCI
12.06
Type
journal article
Language
en
Open access
hybrid
Funders
  • Janssen Research & Development, LLC
  • Janssen Global Services, LLC

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.